Walgreens Boots Alliance (WBA: NSD) has recently experienced a significant fall in their stock value. This stock plunge is primarily attributable to the company’s lowered outlook and disappointing earnings posting. 

WBA: An Overview of Financial Performance

Analyzing the financial metrics of WBA over the trailing 12-month period paints a somewhat concerning picture for capital gain with a significant decline of -45.18%. This precipitous fall situates WBA halfway down the sector in terms of capital gains, with a percentile ranking of 50%.

But what does the drop in the 1-year total return mean for investors? The 1-year dividend return of 5.1% remains strong as evidenced by their sector percentile ranking for this metric at 100%. However, that did not stop the 1-year total return from plummeting to -40.08%, which puts the company in a slightly favorable percentile in comparison to its competitors, at 62.5%.

Market Analyst Coverage on Walgreens Boots:  

Market analysis can be an essential tool for providing context and predicting future trends. For WBA, the coverage seems equally divided. Among the ten analysts covering the stock, the average rating is ‘hold’. The target price varies significantly, with the lowest expectation set at USD 17 and the highest at USD 35, and an average target price of USD 23.15.

Sector analysis is crucial to consider given that WBA functions under the Pharmaceutical Retailers sector within NSD. The average analyst rating for the sector is ‘buy’, and it is rated ‘slightly bearish’ by Stock Target Advisor.

Conclusion:

Stock Target Advisor maintains a ‘neutral’ rating for WBA and sets a target price of 21. Analysts express concerns over Walgreens Boots Alliance Inc.’s struggles, especially in light of the recent lowered full-year outlook.